Targeted drug delivery across the blood-brain barrier using ultrasound technique

Therapeutic Delivery

Volumn 1, Issue 6, 2010, Pages 819-848

  Deng, Cheri X ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CALCIUM; CARMUSTINE; DOXORUBICIN; MONOCLONAL ANTIBODY; TRASTUZUMAB;

BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; CALCIUM CELL LEVEL; CELL TRANSPORT; CENTRAL NERVOUS SYSTEM DISEASE; DRUG BRAIN LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; GLIOMA; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; ULTRASOUND THERAPY; ULTRASOUND TRANSDUCER;

EID: 79954507590     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.10.66     Document Type: Review

References (142)

1. Pardridge WM. The blood-brain barrier: Bottleneck in brain drug development. NeuroRx 2(1), 3-14 (2005). (Pubitemid 40128022)
2. Neugroschl J, Sano M. An update on treatment and prevention strategies for alzheimers disease. Curr. Neurol. Neurosci. Rep. 9(5), 368-376 (2009).
3. Schouten LJ, Rutten J, Huveneers HA, Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 94(10), 2698-2705 (2002). (Pubitemid 34478086)
4. Tosoni A, Ermani M, Brandes AA. The pathogenesis and treatment of brain metastases: a comprehensive review. Crit. Rev. Oncol. Hematol. 52(3), 199-215 (2004). (Pubitemid 39593754)
5. Deeken JF, Loscher W. The blood-brain barrier and cancer: transporters, treatment, and trojan horses. Clin. Cancer. Res. 13(6), 1663-1674 (2007). (Pubitemid 46952931)
6. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol. Dis. 37(1), 13-25 (2010).
7. Cecchelli R, Berezowski V, Lundquist S, et al. Modelling of the blood-brain barrier in drug discovery and development. Nat. Rev. Drug. Discov. 6(8), 650-661 (2007). (Pubitemid 47202487)
8. Juillerat-Jeanneret L. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drugnanoparticles? Drug Discov. Today 13(23-24), 1099-1106 (2008).
9. Abbott NJ. Dynamics of cns barriers: Evolution, differentiation, and modulation. Cell. Mol. Neurobiol. 25(1), 5-23 (2005). (Pubitemid 40558582)
10. Persidsky Y, Ramirez SH, Haorah J, Kanmogne GD. Blood-brain barrier: Structural components and function under physiologic and pathologic conditions. J. Neuroimmune Pharmacol. 1(3), 223-236 (2006). (Pubitemid 44244128)
11. Pardridge WM. Blood-brain barrier delivery. Drug Discov. Today 12(1-2), 54-61 (2007). (Pubitemid 46014479)
12. Levin VA. Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. J. Med. Chem. 23(6), 682-684 (1980). (Pubitemid 11237830)
13. Fung LK, Shin M, Tyler B, Brem H, Saltzman WM. Chemotherapeutic drugs released from polymers: distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat brain. Pharm. Res. 13(5), 671-682 (1996). (Pubitemid 26156217)
14. Gabizon A, Shmeeda H, Barenholz Y. Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies. Clin. Pharmacokinet. 42(5), 419-436 (2003). (Pubitemid 36649037)
15. Vogelbaum MA. Convection enhanced delivery for treating brain tumors and selected neurological disorders: symposium review. J. Neurooncol. 83(1), 97-109 (2007). (Pubitemid 46647172)
16. Bidros DS, Liu JK, Vogelbaum MA. Future of convection-enhanced delivery in the treatment of brain tumors. Future Oncol. 6(1), 117-125 (2010).
17. Sampson JH, Archer G, Pedain C, et al. Poor drug distribution as a possible explanation for the results of the precise trial. J. Neurosurg. 113(2), 301-309 (2009).
18. Kunwar S, Chang S, Westphal M, et al. Phase III randomized trial of CED of IL13-PE38QQR vs gliadel wafers for recurrent glioblastoma. Neuro. Oncol. 12(8), 871-881 (2010).
19. Pardridge WM. Re-engineering biopharmaceuticals for delivery to brain with molecular trojan horses. Bioconjug. Chem. 19(7), 1327-1338 (2008). (Pubitemid 352032329)
20. Greig NH, Daly EM, Sweeney DJ, Rapoport SI. Pharmacokinetics of chlorambucil-tertiary butyl ester, a lipophilic chlorambucil derivative that achieves and maintains high concentrations in brain. Cancer Chemother. Pharmacol. 25(5), 320-325 (1990). (Pubitemid 20048637)
21. Jahnke K, Kraemer DF, Knight KR, et al. Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system. Cancer 112(3), 581-588 (2008). (Pubitemid 351186198)
22. Doolittle ND, Abrey LE, Bleyer WA, et al. New frontiers in translational research in neuro-oncology and the blood-brain barrier: report of the tenth annual blood-brain barrier disruption consortium meeting. Clin. Cancer. Res. 11(2 Pt 1), 421-428 (2005). (Pubitemid 40116864)
23. Kroll RA, Neuwelt EA. Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. Neurosurgery 42(5), 1083-1099 (1998).
24. Riina HA, Fraser JF, Fralin S, Knopman J, Scheff RJ, Boockvar JA. Superselective intraarterial cerebral infusion of bevacizumab: a revival of interventional neuro-oncology for malignant glioma. J. Exp. Ther. Oncol. 8(2), 145-150 (2009).
25. Mitragotri S. Healing sound: The use of ultrasound in drug delivery and other therapeutic applications. Nat. Rev. Drug. Discov. 4(3), 255-260 (2005). (Pubitemid 40372559)
26. Campbell P, Prausnitz MR. Future directions for therapeutic ultrasound. Ultrasound Med. Biol. 33(4), 657 (2007). (Pubitemid 46467085)
27. Deng CX, Xu Q, Apfel RE, Holland CK. In vitro measurements of inertial cavitation thresholds in human blood. Ultrasound Med. Biol. 22(7), 939-948 (1996). (Pubitemid 26320204)
28. Kennedy JE. High-intensity focused ultrasound in the treatment of solid tumours. Nat. Rev. Cancer. 5(4), 321-327 (2005). (Pubitemid 40488637)
29. Vaezy S, Martin R, Crum L. High intensity focused ultrasound: a method of hemostasis. Echocardiography 18(4), 309-315 (2001). (Pubitemid 32579093)
30. Vaezy S, Fujimoto VY, Walker C, Martin RW, Chi EY, Crum LA. Treatment of uterine fibroid tumors in a nude mouse model using high-intensity focused ultrasound. Am. J. Obstet. Gynecol. 183(1), 6-11 (2000). (Pubitemid 30626019)
31. Wu J. Shear stress in cells generated by ultrasound. Prog. Biophys. Mol. Biol. 93(1-3), 363-373 (2007). (Pubitemid 44809397)
32. Collis J, Manasseh R, Liovic P, et al. Cavitation microstreaming and stress fields created by microbubbles. Ultrasonics 50(2), 273-279
33. Vanbavel E. Effects of shear stress on endothelial cells: possible relevance for ultrasound applications. Prog. Biophys. Mol. Biol. 93(1-3), 374-383 (2007).
34. Prentice P, Cuschieri A, Dholakia K, Prausnitz M, Campbell P. Membrane disruption by optically controlled microbubble cavitation. Nature Physics 1(2), 107-110 (2005).
35. Okada K, Kudo N, Niwa K, Yamamoto K. A basic study on sonoporation with microbubbles exposed to pulsed ultrasound. J. Med. Ultrasonics 32, 3-11 (2005). (Pubitemid 40591190)
36. Hallow DM, Mahajan AD, Mccutchen TE, Prausnitz MR. Measurement and correlation of acoustic cavitation with cellular bioeffects. Ultrasound Med. Biol. 32(7), 1111-1122 (2006). (Pubitemid 43994294)
37. Zhou Y, Cui J, Deng CX. Dynamics of sonoporation correlated with acoustic cavitation activities. Biophys. J. 94(7), L51-L53 (2008).
38. Van Wamel A, Kooiman K, Harteveld M, et al. Vibrating microbubbles poking individual cells. Drug transfer into cells via sonoporation. J. Control. Release 112(2), 149-155 (2006).
39. Forbes MM, Steinberg RL, Obrien WD Jr. Examination of intertial cavitation of optison in producing sonoporation of chinese hamster ovary cells. Ultrasound Med. Biol. 34, 2009-2018 (2008).
40. Deng CX, Lizzi FL. A review of physical phenomena associated with ultrasonic contrast agents and illustrative clinical applications. Ultrasound Med. Biol. 28(3), 277-286 (2002). (Pubitemid 34326386)
41. Qin S, Caskey CF, Ferrara KW. Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering. Phys. Med. Biol. 54(6), R27-57 (2009).
42. Lindner JR. Microbubbles in medical imaging: current applications and future directions. Nat. Rev. Drug. Discov. 3(6), 527-532 (2004). (Pubitemid 38807535)
43. Ohl CD, Arora M, Ikink R, et al. Sonoporation from jetting cavitation bubbles. Biophys. J. 91(11), 4285-4295 (2006). (Pubitemid 44887286)
44. Ferrara K, Pollard R, Borden M. Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Annu. Rev. Biomed. Eng. 9, 415-447 (2007). (Pubitemid 350246663)
45. Ferrara KW. Driving delivery vehicles with ultrasound. Adv. Drug. Deliv. Rev. 60(10), 1097-1102 (2008).
46. Price RJ, Skyba DM, Kaul S, Skalak TC. Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. Circulation 98(13), 1264-1267 (1998). (Pubitemid 28443388)
47. Postema M, Van Wamel A, Lancee CT, De Jong N. Ultrasound-induced encapsulated microbubble phenomena. Ultrasound Med. Biol. 30(6), 827-840 (2004). (Pubitemid 38829548)
48. Rosenthal I, Sostaric JZ, Riesz P. Sonodynamic therapy -a review of the synergistic effects of drugs and ultrasound. Ultrason. Sonochem. 11(6), 349-363 (2004). (Pubitemid 39070478)
49. Juffermans LJ, Dijkmans PA, Musters RJ, Visser CA, Kamp O. Transient permeabilization of cell membranes by ultrasound-exposed microbubbles is related to formation of hydrogen peroxide. Am. J. Physiol. Heart Circ. Physiol. 291(4), H1595-H1601 (2006). (Pubitemid 44497663)
50. Okada K, Kudo N, Kondo T, Yamamoto K. Contributions of mechanical and sonochemical effects to cell membrane damage induced by single-shot pulsed ultrasound with adjacent microbubbles. J. Med. Ultrason. 35(4), 169-176 (2008).
51. Deng CX, Xu Q, Apfel RE, Holland CK. Inertial cavitation produced by pulsed ultrasound in controlled host media. J. Acoust. Soc. Am. 100(2 Pt 1), 1199-1208 (1996).
52. Apfel RE, Holland CK. Gauging the likelihood of cavitation from short-pulse, low-duty cycle diagnostic ultrasound. Ultrasound Med. Biol. 17(2), 179-185 (1991).
53. Holland CK, Apfel RE. Thresholds for transient cavitation produced by pulsed ultrasound in a controlled nuclei environment. J. Acoust. Soc. Am. 88(5), 2059-2069 (1990).
54. Kaufmann BA, Lindner JR. Molecular imaging with targeted contrast ultrasound. Curr. Opin. Biotechnol. 18(1), 11-16 (2007). (Pubitemid 46237740)
55. Hernot S, Klibanov AL. Microbubbles in ultrasound-triggered drug and gene delivery. Adv. Drug Deliv. Rev. 60(10), 1153-1166 (2008).
56. Zuber-Jerger I, Schacherer D, Woenckhaus M, Jung EM, Scholmerich J, Klebl F. Contrast-enhanced ultrasound in diagnosing liver malignancy. Clin. Hemorheol. Microcirc. 43(1), 109-118 (2009).
57. Powers J, Averkiou M, Bruce M. Principles of cerebral ultrasound contrast imaging. Cerebrovasc. Dis. 27(Suppl. 2), 14-24 (2009).
58. Phillips LC, Klibanov AL, Bowles DK, Ragosta M, Hossack JA, Wamhoff BR. Focused in vivo delivery of plasmid DNA to the porcine vascular wall via intravascular ultrasound destruction of microbubbles. J. Vasc. Res. 47(3), 270-274 (2010).
59. Otani K, Yamahara K, Ohnishi S, Obata H, Kitamura S, Nagaya N. Nonviral delivery of sirna into mesenchymal stem cells by a combination of ultrasound and microbubbles. J. Control. Release 133(2), 146-153 (2009).
60. Li YS, Davidson E, Reid CN, Mchale AP. Optimising ultrasound-mediated gene transfer (sonoporation) in vitro and prolonged expression of a transgene in vivo: Potential applications for gene therapy of cancer. Cancer Lett. 273(1), 62-69 (2009).
61. Vandenbroucke RE, Lentacker I, Demeester J, De Smedt SC, Sanders NN. Ultrasound assisted sirna delivery using peg-siplex loaded microbubbles. J. Control. Release 126(3), 265-273 (2008).
62. Zarnitsyn VG, Kamaev PP, Prausnitz MR. Ultrasound-enhanced chemotherapy and gene delivery for glioma cells. Technol. Cancer Res. Treat. 6(5), 433-442 (2007). (Pubitemid 47613292)
63. Deng CX. Sonoporation and gene delivery. In: Therapeutic Ultrasound: Mechanisms to Applications. Frenkel V (Ed.). Nova Science Publishers, NY, USA (2010).
64. Mayer CR, Geis NA, Katus HA, Bekeredjian R. Ultrasound targeted microbubble destruction for drug and gene delivery. Expert Opin. Drug Deliv. 5(10), 1121-1138 (2008).
65. Hynynen K. Ultrasound for drug and gene delivery to the brain. Adv. Drug. Deliv. Rev. 60(10), 1209-1217 (2008).
66. Hynynen K. Macromolecular delivery across the blood-brain barrier. Methods Mol. Biol. 480, 175-185 (2009).
67. Vykhodtseva N, Mcdannold N, Hynynen K. Progress and problems in the application of focused ultrasound for blood-brain barrier disruption. Ultrasonics 48(4), 279-296 (2008).
68. Ballantine HT Jr, Bell E, Manlapaz J. Progress and problems in the neurological applications of focused ultrasound. J. Neurosurg. 17, 858-876 (1960).
69. Patrick JT, Nolting MN, Goss SA, et al. Ultrasound and the blood-brain barrier. Adv. Exp. Med. Biol. 267, 369-381 (1990).
70. Vykhodtseva NI, Hynynen K, Damianou C. Histologic effects of high intensity pulsed ultrasound exposure with subharmonic emission in rabbit brain in vivo. Ultrasound Med. Biol. 21(7), 969-979 (1995).
71. Sheikov N, Mcdannold N, Jolesz F, Zhang YZ, Tam K, Hynynen K. Brain arterioles show more active vesicular transport of blood-borne tracer molecules than capillaries and venules after focused ultrasound-evoked opening of the blood-brain barrier. Ultrasound Med. Biol. 32(9), 1399-1409 (2006). (Pubitemid 44332656)
72. Hynynen K, Mcdannold N, Vykhodtseva N, Jolesz FA. Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology 220(3), 640-646 (2001). (Pubitemid 32799969)
73. Hynynen K, Mcdannold N, Sheikov NA, Jolesz FA, Vykhodtseva N. Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications. Neuroimage 24(1), 12-20 (2005). (Pubitemid 39611021)
74. Kinoshita M, Mcdannold N, Jolesz FA, Hynynen K. Noninvasive localized delivery of herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption. Proc. Natl Acad. Sci. USA 103(31), 11719-11723 (2006). (Pubitemid 44182517)
75. Kinoshita M, Mcdannold N, Jolesz FA, Hynynen K. Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound. Biochem. Biophys. Res. Commun. 340(4), 1085-1090 (2006). (Pubitemid 43083389)
76. Mesiwala AH, Farrell L, Wenzel HJ, et al. High-intensity focused ultrasound selectively disrupts the blood-brain barrier in vivo. Ultrasound Med. Biol. 28(3), 389-400 (2002). (Pubitemid 34308920)
77. Choi JJ, Pernot M, Brown TR, Small SA, Konofagou EE. Spatio-temporal analysis of molecular delivery through the blood-brain barrier using focused ultrasound. Phys. Med. Biol. 52(18), 5509-5530 (2007). (Pubitemid 350056681)
78. Ng KY, Liu Y. Therapeutic ultrasound: its application in drug delivery. Med. Res. Rev. 22(2), 204-223 (2002). (Pubitemid 34160585)
79. Mcdannold N, Vykhodtseva N, Hynynen K. Targeted disruption of the blood-brain barrier with focused ultrasound: association with cavitation activity. Phys. Med. Biol. 51(4), 793-807 (2006).
80. Mcdannold N, Vykhodtseva N, Hynynen K. Effects of acoustic parameters and ultrasound contrast agent dose on focused-ultrasound induced blood-brain barrier disruption. Ultrasound Med. Biol. 34(6), 930-937 (2008). (Pubitemid 351697595)
81. Hynynen K, Mcdannold N, Martin H, Jolesz FA, Vykhodtseva N. The threshold for brain damage in rabbits induced by bursts of ultrasound in the presence of an ultrasound contrast agent (optison). Ultrasound Med. Biol. 29(3), 473-481 (2003). (Pubitemid 36434336)
82. Sheikov N, Mcdannold N, Vykhodtseva N, Jolesz F, Hynynen K. Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles. Ultrasound Med. Biol. 30(7), 979-989 (2004). (Pubitemid 39094314)
83. Mcdannold N, Vykhodtseva N, Jolesz FA, Hynynen K. MRI investigation of the threshold for thermally induced blood-brain barrier disruption and brain tissue damage in the rabbit brain. Magn. Reson. Med. 51(5), 913-923 (2004). (Pubitemid 38580603)
84. Mcdannold N, Vykhodtseva N, Raymond S, Jolesz FA, Hynynen K. MRI-guided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits. Ultrasound Med. Biol. 31(11), 1527-1537 (2005). (Pubitemid 41606266)
85. Hynynen K, Mcdannold N, Vykhodtseva N, et al. Focal disruption of the blood-brain barrier due to 260-khz ultrasound bursts: a method for molecular imaging and targeted drug delivery. J. Neurosurg. 105(3), 445-454 (2006). (Pubitemid 44358757)
86. Choi JJ, Pernot M, Small SA, Konofagou EE. Noninvasive, transcranial and localized opening of the blood-brain barrier using focused ultrasound in mice. Ultrasound Med. Biol. 33(1), 95-104 (2007). (Pubitemid 44959316)
87. Treat LH, Mcdannold N, Vykhodtseva N, Zhang Y, Tam K, Hynynen K. Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. Int. J. Cancer 121(4), 901-907 (2007). (Pubitemid 47106223)
88. Choi JJ, Wang S, Tung YS, Morrison B, 3rd, Konofagou EE. Molecules of various pharmacologically-relevant sizes can cross the ultrasound-induced blood-brain barrier opening in vivo. Ultrasound Med. Biol. 36(1), 58-67 (2010).
89. Mcdannold N, Clement GT, Black P, Jolesz F, Hynynen K. Transcranial magnetic resonance imaging-guided focused ultrasound surgery of brain tumors: initial findings in patients. Neurosurgery 66(2), 323-332 (2010).
90. Hynynen K. MRI-guided focused ultrasound treatments. Ultrasonics 50(2), 221-229 (2010).
91. Fry FJ, Barger JE. Acoustical properties of the human skull. J. Acoust. Soc. Am. 63(5), 1576-1590 (1978). (Pubitemid 8346211)
92. Marquet F, Pernot M, Aubry JF, et al. Non-invasive transcranial ultrasound therapy based on a 3D ct scan: Protocol validation and in vitro results. Phys. Med. Biol. 54(9), 2597-2613 (2009).
93. White PJ, Clement GT, Hynynen K. Local frequency dependence in transcranial ultrasound transmission. Phys. Med. Biol. 51(9), 2293-2305 (2006).
94. Hynynen K, Sun J. Trans-skull ultrasound therapy: the feasibility of using image-derived skull thickness information to correct the phase distortion. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 46(3), 752-755 (1999).
95. White J, Clement GT, Hynynen K. Transcranial ultrasound focus reconstruction with phase and amplitude correction. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 52(9), 1518-1522 (2005). (Pubitemid 41560462)
96. Clement GT, Hynynen K. Correlation of ultrasound phase with physical skull properties. Ultrasound Med. Biol. 28(5), 617-624 (2002). (Pubitemid 34665419)
97. Hynynen K, Clement GT, Mcdannold N, et al. 500-element ultrasound phased array system for noninvasive focal surgery of the brain: A preliminary rabbit study with ex vivo human skulls. Magn. Reson. Med. 52(1), 100-107 (2004). (Pubitemid 39295261)
98. Jordao JF, Ayala-Grosso CA, Markham K, et al. Antibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-b plaque load in the tgcrnd8 mouse model of alzheimers disease. PLoS One 5(5), e10549 (2010).
99. Baselga J. Current and planned clinical trials with trastuzumab (herceptin). Semin. Oncol. 27(5 Suppl. 9), 27-32 (2000).
100. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J. Clin. 59(4), 225-249 (2009).
101. Grossman SA, Batara JF. Current management of glioblastoma multiforme. Semin. Oncol. 31(5), 635-644 (2004). (Pubitemid 39389014)
102. Grossman SA, Oneill A, Grunnet M, et al. Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group trial 2394. J. Clin. Oncol. 21(8), 1485-1491 (2003). (Pubitemid 46594100)
103. Liu HL, Hua MY, Chen PY, et al. Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment. Radiology 255(2), 415-425 (2010).
104. Xie F, Boska MD, Lof J, Uberti MG, Tsutsui JM, Porter TR. Effects of transcranial ultrasound and intravenous microbubbles on blood brain barrier permeability in a large animal model. Ultrasound Med. Biol. 34(12), 2028-2034 (2008).
105. Sassaroli E, Hynynen K. Cavitation threshold of microbubbles in gel tunnels by focused ultrasound. Ultrasound Med. Biol. 33(10), 1651-1660 (2007). (Pubitemid 47444489)
106. Sassaroli E, Hynynen K. Forced linear oscillations of microbubbles in blood capillaries. J. Acoust. Soc. Am. 115(6), 3235-3243 (2004). (Pubitemid 38781255)
107. Qin S, Ferrara KW. Acoustic response of compliable microvessels containing ultrasound contrast agents. Phys. Med. Biol. 51(20), 5065-5088 (2006). (Pubitemid 44540119)
108. Goertz DE, Wright C, Hynynen K. Contrast agent kinetics in the rabbit brain during exposure to therapeutic ultrasound. Ultrasound Med. Biol. 36(6), 916-924 (2010).
109. Chopra R, Vykhodtseva N, Hynynen K. Influence of exposure time and pressure amplitude on blood-brain-barrier opening using transcranial ultrasound exposures. ACS Chem. Neurosci. 1(5), 391-398 (2010).
110. Mcdannold N, Vykhodtseva N, Hynynen K. Blood-brain barrier disruption induced by focused ultrasound and circulating preformed microbubbles appears to be characterized by the mechanical index. Ultrasound. Med. Biol. 34(5), 834-840 (2008). (Pubitemid 351608039)
111. Choi JJ, Feshitan JA, Baseri B, et al. Microbubble-size dependence of focused ultrasound-induced blood-brain barrier opening in mice in vivo. IEEE Trans. Biomed. Eng. 57(1), 145-154 (2010).
112. Tu J, Hwang JH, Matula TJ, Brayman AA, Crum LA. Intravascular inertial cavitation activity detection and quantification in vivo with optison. Ultrasound Med. Biol. 32(10), 1601-1609 (2006). (Pubitemid 44528118)
113. Zhou Y, Shi J, Cui J, Deng CX. Effects of extracellular calcium on cell membrane resealing in sonoporation. J. Control. Release 126(1), 34-43 (2008).
114. Tung YS, Choi JJ, Baseri B, Konofagou EE. Identifying the inertial cavitation threshold and skull effects in a vessel phantom using focused ultrasound and microbubbles. Ultrasound Med. Biol. 36(5), 840-852 (2010).
115. Kumon RE, Aehle M, Sabens D, et al. Spatiotemporal effects of sonoporation measured by real-time calcium imaging. Ultrasound Med. Biol. 35(3), 494-506 (2009).
116. Kumon RE, Aehle M, Sabens D, Parikh P, Kourennyi D, Deng CX. Ultrasoundinduced calcium oscillations and waves in chinese hamster ovary cells in the presence of microbubbles. Biophys. J. 93(6), L29-L31 (2007). (Pubitemid 47437567)
117. Fan Z, Kumon RE, Park J, Deng CX. Intracellular delivery and calcium transients generated in sonoporation facilitated by microbubbles. J. Control. Release. 142(1), 31-39 (2010).
118. Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84(3), 345-357 (1996). (Pubitemid 26058560)
119. Nigam SK, Rodriguez-Boulan E, Silver RB. Changes in intracellular calcium during the development of epithelial polarity and junctions. Proc. Natl Acad. Sci. USA 89(13), 6162-6166 (1992).
120. Shasby DM, Shasby SS. Effects of calcium on transendothelial albumin transfer and electrical resistance. J. Appl. Physiol. 60(1), 71-79 (1986). (Pubitemid 16024015)
121. Stuart RO, Sun A, Panichas M, Hebert SC, Brenner BM, Nigam SK. Critical role for intracellular calcium in tight junction biogenesis. J. Cell. Physiol. 159(3), 423-433 (1994). (Pubitemid 24188982)
122. Stuart RO, Sun A, Bush KT, Nigam SK. Dependence of epithelial intercellular junction biogenesis on thapsigargin-sensitive intracellular calcium stores. J. Biol. Chem. 271(23), 13636-13641 (1996). (Pubitemid 26185412)
123. Abbott NJ. Role of intracellular calcium in regulation of brain endothelial permeability. In: Introduction to the Blood-Brain Barrier: Methodology, Biology and Pathology. Pardridge WM (Ed.). Cambridge University Press, NY, USA 345-351 (1998).
124. Brown RC, Davis TP. Calcium modulation of adherens and tight junction function: a potential mechanism for blood-brain barrier disruption after stroke. Stroke 33(6), 1706-1711 (2002). (Pubitemid 34619982)
125. Revest PA, Abbott NJ, Gillespie JI. Receptor-mediated changes in intracellular [Ca2+] in cultured rat brain capillary endothelial cells. Brain. Res. 549(1), 159-161 (1991).
126. Park J, Fan Z, Kumon RE, El-Sayed ME, Deng CX. Modulation of intracellular Ca2+ concentration in brain microvascular endothelial cells in vitro by acoustic cavitation. Ultrasound Med. Biol. 36(7), 1176-1187 (2010).
127. Paemeleire K, De Hemptinne A, Leybaert L. Chemically, mechanically, and hyperosmolarity-induced calcium responses of rat cortical capillary endothelial cells in culture. Exp. Brain Res. 126(4), 473-481 (1999). (Pubitemid 29281450)
128. Abbott NJ. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell. Mol. Neurobiol. 20(2), 131-147 (2000). (Pubitemid 30091452)
129. Sheikov N, Mcdannold N, Sharma S, Hynynen K. Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium. Ultrasound Med. Biol. 34(7), 1093-1104 (2008). (Pubitemid 351893156)
130. Raymond SB, Treat LH, Dewey JD, Mcdannold NJ, Hynynen K, Bacskai BJ. Ultrasound enhanced delivery of molecular imaging and therapeutic agents in Alzheimers disease mouse models. PLoS One 3(5), e2175 (2008).
131. Pernot M, Aubry JF, Tanter M, et al. In vivo transcranial brain surgery with an ultrasonic time reversal mirror. J. Neurosurg. 106(6), 1061-1066 (2007). (Pubitemid 46871120)
132. Gateau J, Marsac L, Pernot M, Aubry JF, Tanter M, Fink M. Transcranial ultrasonic therapy based on time reversal of acoustically induced cavitation bubble signature. IEEE Trans. Biomed. Eng. 57(1), 134-144 (2010).
133. Chopra R, Curiel L, Staruch R, Morrison L, Hynynen K. An MRI-compatible system for focused ultrasound experiments in small animal models. Med. Phys. 36(5), 1867-1874 (2009).
134. Liu HL, Wai YY, Chen WS, et al. Hemorrhage detection during focused-ultrasound induced blood-brainbarrier opening by using susceptibilityweighted magnetic resonance imaging. Ultrasound Med. Biol. 34(4), 598-606 (2008).
135. Liu HL, Hsu PH, Chu PC, et al. Magnetic resonance imaging enhanced by superparamagnetic iron oxide particles: usefulness for distinguishing between focused ultrasound-induced blood-brain barrier disruption and brain hemorrhage. J. Magn. Reson. Imaging 29(1), 31-38 (2009).
136. Lin KJ, Liu HL, Hsu PH, et al. Quantitative micro-spect/ct for detecting focused ultrasound-induced blood-brain barrier opening in the rat. Nucl. Med. Biol. 36(7), 853-861 (2009).
137. Kaufmann BA, Wei K, Lindner JR. Contrast echocardiography. Curr. Probl. Cardiol. 32(2), 51-96 (2007). (Pubitemid 46037828)
138. O'Brien WD Jr. Ultrasound-biophysics mechanisms. Prog. Biophys. Mol. Biol. 93(1-3), 212-255 (2007).
139. Dayton PA, Allen JS, Ferrara KW. The magnitude of radiation force on ultrasound contrast agents. J. Acoust. Soc. Am. 112(5 Pt 1), 2183-2192 (2002). (Pubitemid 35222484)
140. Blomley MJ, Cooke JC, Unger EC, Monaghan MJ, Cosgrove DO. Microbubble contrast agents: a new era in ultrasound. BMJ 322(7296), 1222-1225 (2001).
141. Borden MA, Zhang H, Gillies RJ, Dayton PA, Ferrara KW. A stimulus-responsive contrast agent for ultrasound molecular imaging. Biomaterials 29(5), 597-606 (2008). (Pubitemid 350100802)
142. Koo YE, Reddy GR, Bhojani M, et al. Brain cancer diagnosis and therapy with nanoplatforms. Adv. Drug. Deliv. Rev. 58(14), 1556-1577 (2006). (Pubitemid 44820505)